These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16636338)

  • 21. Gene expression profiles of breast cancer obtained from core cut biopsies before neoadjuvant docetaxel, adriamycin, and cyclophoshamide chemotherapy correlate with routine prognostic markers and could be used to identify predictive signatures.
    Rody A; Karn T; Gätje R; Kourtis K; Minckwitz G; Loibl S; Munnes M; Ruckhäberle E; Holtrich U; Kaufmann M; Ahr A
    Zentralbl Gynakol; 2006 Apr; 128(2):76-81. PubMed ID: 16673249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microarray-based gene expression profiling as a clinical tool for breast cancer management: are we there yet?
    Correa Geyer F; Reis-Filho JS
    Int J Surg Pathol; 2009 Aug; 17(4):285-302. PubMed ID: 19103611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary tumour expression of the cysteine cathepsin inhibitor Stefin A inhibits distant metastasis in breast cancer.
    Parker BS; Ciocca DR; Bidwell BN; Gago FE; Fanelli MA; George J; Slavin JL; Möller A; Steel R; Pouliot N; Eckhardt B; Henderson MA; Anderson RL
    J Pathol; 2008 Feb; 214(3):337-46. PubMed ID: 17985332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis.
    Han HJ; Russo J; Kohwi Y; Kohwi-Shigematsu T
    Nature; 2008 Mar; 452(7184):187-93. PubMed ID: 18337816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The molecular outlook.
    Caldas C; Aparicio SA
    Nature; 2002 Jan; 415(6871):484-5. PubMed ID: 11831227
    [No Abstract]   [Full Text] [Related]  

  • 26. Pathway analysis of gene signatures predicting metastasis of node-negative primary breast cancer.
    Yu JX; Sieuwerts AM; Zhang Y; Martens JW; Smid M; Klijn JG; Wang Y; Foekens JA
    BMC Cancer; 2007 Sep; 7():182. PubMed ID: 17894856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genomics and proteomics of bone cancer.
    Marguiles AG; Klimberg VS; Bhattacharrya S; Gaddy D; Suva LJ
    Clin Cancer Res; 2006 Oct; 12(20 Pt 2):6217s-6221s. PubMed ID: 17062704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prognostic molecular classification of breast cancers based on gene expression profiling].
    Feng YM; Li XQ; Sun BC; Gao XC; Gu L; Niu Y; Hao XS
    Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):900-6. PubMed ID: 17533740
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and evaluation of therapeutically relevant predictive classifiers using gene expression profiling.
    Simon R
    J Natl Cancer Inst; 2006 Sep; 98(17):1169-71. PubMed ID: 16954463
    [No Abstract]   [Full Text] [Related]  

  • 30. A polymorphism in the G protein beta3-subunit gene is associated with bone metastasis risk in breast cancer patients.
    Clar H; Langsenlehner U; Krippl P; Renner W; Leithner A; Gruber G; Hofmann G; Yazdani-Biuki B; Langsenlehner T; Windhager R
    Breast Cancer Res Treat; 2008 Oct; 111(3):449-52. PubMed ID: 17978878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-10b and breast cancer metastasis.
    Gee HE; Camps C; Buffa FM; Colella S; Sheldon H; Gleadle JM; Ragoussis J; Harris AL
    Nature; 2008 Oct; 455(7216):E8-9; author reply E9. PubMed ID: 18948893
    [No Abstract]   [Full Text] [Related]  

  • 32. Bone metastasis is strongly associated with estrogen receptor-positive/progesterone receptor-negative breast carcinomas.
    Wei B; Wang J; Bourne P; Yang Q; Hicks D; Bu H; Tang P
    Hum Pathol; 2008 Dec; 39(12):1809-15. PubMed ID: 18715613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of a metastasis signature and the DLX4 homeobox protein as a regulator of metastasis by combined transcriptome approach.
    Tomida S; Yanagisawa K; Koshikawa K; Yatabe Y; Mitsudomi T; Osada H; Takahashi T
    Oncogene; 2007 Jul; 26(31):4600-8. PubMed ID: 17260014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Matrix metalloproteinase-1 is a crucial bone metastasis factor in a human breast cancer-derived highly invasive cell line.
    Okuyama N; Matsumine A; Kosugi R; Wakabayashi H; Uchida A
    Oncol Rep; 2008 Dec; 20(6):1497-504. PubMed ID: 19020733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential effect of doxorubicin and zoledronic acid on intraosseous versus extraosseous breast tumor growth in vivo.
    Ottewell PD; Deux B; Mönkkönen H; Cross S; Coleman RE; Clezardin P; Holen I
    Clin Cancer Res; 2008 Jul; 14(14):4658-66. PubMed ID: 18628481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Predictive and prognostic markers of breast cancer. Molecular biological analysis of fixed tumor tissue].
    Petry C; Gehrmann M; von Törne C; Weber K; Stropp U; Hennig G
    Pathologe; 2008 Nov; 29 Suppl 2():181-3. PubMed ID: 18843491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular assays to predict prognosis of breast cancer.
    Paik S
    Clin Adv Hematol Oncol; 2007 Sep; 5(9):681-2. PubMed ID: 17982408
    [No Abstract]   [Full Text] [Related]  

  • 38. Gene expression of the invasive phenotype of TNF-alpha-treated MCF-7 cells.
    Yin Y; Chen X; Shu Y
    Biomed Pharmacother; 2009 Jul; 63(6):421-8. PubMed ID: 19564093
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genes associated with breast cancer metastatic to bone.
    Smid M; Wang Y; Klijn JG; Sieuwerts AM; Zhang Y; Atkins D; Martens JW; Foekens JA
    J Clin Oncol; 2006 May; 24(15):2261-7. PubMed ID: 16636340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lineage infidelity and expression of melanocytic markers in human breast cancer.
    Bachmeier BE; Nerlich AG; Mirisola V; Jochum M; Pfeffer U
    Int J Oncol; 2008 Nov; 33(5):1011-5. PubMed ID: 18949364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.